Faunce, Thomas; Urbas, Gregor; Skillen, Lesley Ann
This article critically analyses the prospects for introducing United States anti-fraud (or anti-false claims) laws in the Australian health care setting. Australian governments spend billions of dollars each year on medicines and health care. A recent report estimates that the money lost to corporate fraud in Australia is growing at an annual rate of 7%, but that only a third of the losses are currently being detected. In the US, qui tam provisions - the component of anti-fraud or anti-false...[Show more]
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.